EGFR Tyrosine Kinase Inhibitors Prolong Overall Survival in EGFR Mutated Non-Small-Cell Lung Cancer Patients with Postsurgical Recurrence . Journal of Cancer Research Updates, [S. l.], v. 1, n. 1, p.  102–107, 2012. DOI: 10.6000/1929-2279.2012.01.01.15. Disponível em: https://mail.neoplasiaresearch.com/index.php/jcru/article/view/380. Acesso em: 22 nov. 2026.